FIXX RSI Chart
Last 7 days
15.5%
Last 30 days
25.7%
Last 90 days
111.6%
Trailing 12 Months
62.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 7.3M | 6.9M | 7.5M | 3.2M |
2022 | 27.1M | 20.3M | 13.5M | 6.7M |
2021 | 31.4M | 33.0M | 34.1M | 34.0M |
2020 | 1.9M | 2.2M | 2.4M | 2.7M |
2019 | 4.5M | 4.8M | 4.9M | 1.7M |
2018 | 0 | 0 | 4.3M | 4.3M |
2017 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 25, 2024 | alloway paul | acquired | - | - | 23,530 | see remarks |
Mar 25, 2024 | michaud charles jr | acquired | - | - | 6,448 | see remarks |
Jan 09, 2024 | tzianabos arthur | sold | -7,445 | 0.5711 | -13,037 | - |
Jan 03, 2024 | alloway paul | sold | -4,120 | 0.566 | -7,280 | see remarks |
Jan 03, 2024 | michaud charles jr | sold | -975 | 0.571 | -1,708 | see remarks |
Jan 01, 2024 | michaud charles jr | acquired | - | - | 4,240 | see remarks |
Jan 01, 2024 | tzianabos arthur | acquired | - | - | 33,420 | - |
Jan 01, 2024 | alloway paul | acquired | - | - | 18,610 | see remarks |
Sep 06, 2023 | seymour albert | acquired | - | - | 4,620 | see remarks |
Sep 06, 2023 | seymour albert | sold | -1,665 | 1.1502 | -1,448 | see remarks |
Which funds bought or sold FIXX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -14,379 | - | -% |
May 15, 2024 | Newtyn Management, LLC | sold off | -100 | -850,750 | - | -% |
May 15, 2024 | STATE STREET CORP | sold off | -100 | -81,353 | - | -% |
May 15, 2024 | Tudor Investment Corp Et Al | sold off | -100 | -70,299 | - | -% |
May 15, 2024 | HSBC HOLDINGS PLC | sold off | -100 | -9,320 | - | -% |
May 15, 2024 | MORGAN STANLEY | sold off | -100 | -7,939 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -114,894 | - | -% |
May 15, 2024 | BARCLAYS PLC | sold off | -100 | -33,000 | - | -% |
May 15, 2024 | ADAR1 Capital Management, LLC | sold off | -100 | -178,555 | - | -% |
May 15, 2024 | 5AM Venture Management, LLC | sold off | -100 | -2,757,840 | - | -% |
Unveiling Homology Medicines Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Homology Medicines Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Homology Medicines Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | - | - | - | 1,423,000 | 354,000 | 1,469,000 | 4,245,000 | 802,000 | 802,000 | 802,000 | 802,000 | 1,677,000 | 2,187,000 | 29,305,000 | 980,000 | 567,000 | 567,000 | 588,000 | 1,124,500 | 1,661,000 | 1,703,000 | 1,271,000 |
Operating Expenses | 130.4% | 14,843,000 | -48,880,000 | 31,001,000 | 31,170,000 | 28,313,000 | -55,317,000 | 33,664,000 | 29,109,000 | 38,420,000 | 34,427,000 | 32,338,000 | 32,739,000 | 30,416,000 | 30,781,500 | 28,840,000 | 36,264,000 | 37,080,000 | 26,122,000 | 31,729,000 | 28,365,000 | 25,393,000 |
S&GA Expenses | 100.0% | - | -13,480,000 | 6,842,000 | 8,188,000 | 8,325,000 | -19,929,000 | 7,810,000 | 8,034,000 | 14,147,000 | 10,781,000 | 8,351,000 | 9,042,000 | 8,661,000 | 7,587,000 | 8,423,000 | 8,793,000 | 7,770,000 | 5,779,000 | 6,038,000 | 5,538,000 | 4,857,000 |
R&D Expenses | 134.2% | 9,841,000 | -28,760,000 | 17,519,000 | 22,982,000 | 19,988,000 | -35,388,000 | 25,854,000 | 21,075,000 | 24,273,000 | 23,646,000 | 23,987,000 | 23,697,000 | 21,755,000 | 23,194,500 | 20,417,000 | 27,471,000 | 29,310,000 | 20,343,000 | 25,691,000 | 22,827,000 | 20,536,000 |
EBITDA Margin | 0% | -16.32 | -16.32 | -21.62 | -23.84 | -22.17 | -6.38 | 0.27 | 0.32 | 0.20 | -2.57 | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | -100.0% | - | 318,000 | - | - | - | -851,000 | -46,000 | 105,000 | 967,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -100.0% | - | 31,500,000 | -29,578,000 | -29,305,000 | -26,042,000 | -76,984,000 | -31,593,000 | -27,833,000 | 93,663,000 | -33,583,000 | -30,608,000 | -30,500,000 | -1,073,000 | - | - | - | - | - | - | - | - |
EBT Margin | 0% | -16.46 | -16.46 | -21.61 | -23.86 | -22.20 | -6.43 | 0.05 | 0.08 | -0.04 | -2.82 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -97.7% | 1,000,000 | 43,099,000 | -32,954,000 | -35,044,000 | -28,844,000 | -72,099,000 | -33,726,000 | -29,089,000 | 92,105,000 | -33,583,000 | -30,608,000 | -30,500,000 | -1,073,000 | -29,791,000 | -28,232,000 | -35,340,000 | -35,331,000 | -24,167,000 | -29,627,000 | -26,270,000 | -23,852,000 |
Net Income Margin | 55.5% | -7.36 | -16.56 | -22.55 | -24.70 | -22.38 | -6.44 | -0.32 | -0.06 | -0.10 | -2.82 | -2.69 | -2.71 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -125.9% | -14,551,000 | 56,201,000 | -24,941,000 | -23,660,000 | -26,282,000 | 74,296,000 | -24,938,000 | -30,967,000 | -31,833,000 | -30,768,000 | -25,864,000 | -24,875,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 223.7% | 152 | 47.00 | 140 | 169 | 198 | 62.00 | 263 | 285 | 311 | 212 | 231 | 259 | 235 | 264 | 228 | 258 | 289 | 311 | 317 | 341 | 233 |
Current Assets | 380.7% | 138 | 29.00 | 107 | 131 | 154 | 47.00 | 213 | 238 | 262 | 192 | 192 | 218 | 192 | 220 | 181 | 210 | 238 | 267 | 274 | 299 | 191 |
Cash Equivalents | 353.4% | 116 | 26.00 | 29.00 | 77.00 | 39.00 | 44.00 | 43.00 | 176 | 248 | 33.00 | 96.00 | 116 | 104 | 217 | 178 | 168 | 143 | 54.00 | 78.00 | 116 | 41.00 |
Net PPE | -6.9% | 2.00 | 2.00 | - | 1.00 | 1.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 33.00 | 34.00 | 36.00 | 37.00 | 40.00 | 41.00 | 43.00 | 43.00 | 41.00 | 41.00 | 41.00 |
Liabilities | -12.6% | 104 | 119 | 52.00 | 50.00 | 46.00 | 81.00 | 54.00 | 44.00 | 45.00 | 42.00 | 32.00 | 34.00 | 34.00 | 68.00 | 58.00 | 64.00 | 62.00 | 52.00 | 59.00 | 56.00 | 59.00 |
Current Liabilities | 133.6% | 33.00 | 14.00 | 25.00 | 23.00 | 19.00 | 58.00 | 25.00 | 21.00 | 21.00 | 17.00 | 19.00 | 20.00 | 18.00 | 23.00 | 17.00 | 20.00 | 17.00 | 12.00 | 19.00 | 15.00 | 18.00 |
Long Term Debt | -100.0% | - | 39.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Current | - | - | - | - | - | - | 32.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 39.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -33.2% | 49.00 | 73.00 | 88.00 | 119 | 152 | 178 | 209 | 240 | 266 | 170 | 199 | 225 | 201 | 196 | 170 | 195 | 227 | 259 | 258 | 285 | 174 |
Retained Earnings | 0.5% | -186 | -187 | -525 | -493 | -457 | -133 | -394 | -361 | -332 | -424 | -390 | -359 | -329 | -328 | -298 | -270 | -235 | -199 | -175 | -145 | -119 |
Additional Paid-In Capital | 5546.2% | 235 | 4.00 | 614 | 612 | 610 | 3.00 | 604 | 601 | 598 | 594 | 589 | 585 | 530 | 524 | 469 | 465 | 462 | 458 | 433 | 430 | 294 |
Shares Outstanding | 59.6% | 12.00 | 7.00 | 3.00 | 3.00 | 3.00 | 7.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 46.00 | - | - | - | 92.00 | - | - | - | 339 | - | - | - | 512 | - | - | - | 514 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -126.0% | -14,551 | 55,978 | -24,941 | -23,660 | -26,054 | 75,505 | -24,932 | -30,846 | -30,684 | -30,430 | -25,387 | -24,111 | -29,823 | -11,612 | -28,887 | -27,987 | -25,846 | -26,333 | -25,484 | -21,670 | -17,871 |
Share Based Compensation | 108.3% | 417 | -5,049 | 1,706 | 2,402 | 2,369 | -8,727 | 2,771 | 3,143 | 4,051 | 4,663 | 4,226 | 4,473 | 3,883 | 3,566 | 3,346 | 3,453 | 2,883 | 2,436 | 1,986 | 1,970 | 1,243 |
Cashflow From Investing | 100.1% | 97.00 | -69,615 | -22,763 | 61,001 | 31,372 | -21,191 | -108,218 | -41,369 | 168,312 | 43,661 | 4,524 | -13,738 | -85,235 | -955 | 38,844 | 52,010 | 114,997 | -20,027 | -13,137 | -38,302 | 19,667 |
Cashflow From Financing | 41995.8% | 99,346 | 236 | 18.00 | 2.00 | 150 | 29,505 | 124 | - | 440 | 1.00 | 379 | 49,746 | 2,043 | 51,995 | 410 | 241 | 447 | 22,575 | 614 | 134,699 | 325 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Collaboration arrangement revenue | $ 0 | $ 2,947 |
Operating expenses: | ||
Research and development | 9,841 | 7,910 |
General and administrative | 5,002 | 2,410 |
Total operating expenses | 14,843 | 10,320 |
Loss from operations | (14,843) | (7,373) |
Change in fair value of convertible notes | 15,890 | (43) |
Other income (expense), net | 158 | 578 |
Total other income (expense), net | 16,048 | 535 |
Income (loss) before provision for income taxes | 1,205 | (6,838) |
Loss from equity method investment | (176) | 0 |
Net income (loss) | $ 1,029 | $ (6,838) |
Net income (loss) per share - basic | $ 1.03 | $ (19.84) |
Net income (loss) per share - diluted | $ (6.33) | $ (19.84) |
Weighted-average common shares - basic | 995,280 | 344,623 |
Weighted-average common shares - diluted | 2,334,180 | 344,623 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 115,509 | $ 25,617 |
Short-term investments | 19,803 | 0 |
Prepaid expenses and other current assets | 2,731 | 3,099 |
Total current assets | 138,043 | 28,716 |
Equity method investment | 4,724 | 0 |
Property and equipment, net | 1,659 | 1,782 |
Right-of-use asset, operating leases | 6,160 | 6,301 |
Restricted cash and restricted cash equivalents | 647 | 5,647 |
Other noncurrent assets | 1,101 | 4,611 |
Total assets | 152,334 | 47,057 |
Current liabilities: | ||
Accounts payable | 4,960 | 3,468 |
Accrued expenses and other current liabilities | 19,825 | 9,763 |
CVR liability | 5,080 | 0 |
Venture debt, current portion | 3,088 | 878 |
Total current liabilities | 32,953 | 14,109 |
Lease liability, net of current portion | 6,099 | 6,248 |
Venture debt, net of current portion | 9,400 | 4,581 |
Convertible notes | 0 | 38,595 |
Other noncurrent liabilities | 55,113 | 55,000 |
Total liabilities | 103,565 | 118,533 |
Commitments and contingencies (Note 10) | ||
Temporary equity, convertible preferred stock | 0 | 111,445 |
Stockholders' deficit: | ||
Common stock, $0.0001 par value; 400,000,000 shares authorized, 11,929,520 and 359,569 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 2 | 1 |
Additional paid-in capital | 234,824 | 4,159 |
Accumulated other comprehensive loss | (5) | 0 |
Accumulated deficit | (186,052) | (187,081) |
Total stockholders' equity (deficit) | 48,769 | (182,921) |
Total liabilities, convertible preferred stock and stockholders' deficit | 152,334 | 47,057 |
Series A convertible preferred stock [Member] | ||
Current liabilities: | ||
Temporary equity, convertible preferred stock | 0 | 47,458 |
Series A-1 convertible preferred stock [Member] | ||
Current liabilities: | ||
Temporary equity, convertible preferred stock | 0 | 4,132 |
Series B convertible preferred stock [Member] | ||
Current liabilities: | ||
Temporary equity, convertible preferred stock | $ 0 | $ 59,855 |